Diffuse Cytotoxic Lesions of the Corpus Callosum Following Folinic Acid, Fluorouracil, and Oxaliplatin (FOLFOX) Chemotherapy: A Case Report

Cytotoxic lesions of the corpus callosum (CLOCCs) are a neuroradiological pattern associated with diverse conditions, including drug-related toxicity. Although commonly centered in the splenium, lesions may extend throughout the corpus callosum and into adjacent white matter. We report the case of a 38-year-old woman with metastatic colonic adenocarcinoma who developed acute confusion and visual disturbances four days after initiation of her first cycle of folinic acid, fluorouracil, and oxaliplatin (FOLFOX). Neurological examination revealed right-eye exotropia without motor or sensory deficits. Laboratory investigations, including serum ammonia, were unremarkable. Brain magnetic resonance imaging (MRI) demonstrated bilateral, symmetric T2-weighted/fluid-attenuated inversion recovery (FLAIR) hyperintensities involving the entire corpus callosum and periventricular white matter, with restricted diffusion, reduced apparent diffusion coefficient (ADC), and no contrast enhancement. These findings supported a diagnosis of FOLFOX-associated CLOCCs, potentially related to 5-fluorouracil (5-FU) neurotoxicity. Complete neurological recovery occurred within 24 hours, and follow-up MRI at one month showed complete resolution. FOLFOX was subsequently resumed with a 25% reduction in the 5-FU dose and close monitoring, without neurological recurrence or other observed complications. This case illustrates that extensive callosal involvement can accompany a rapidly reversible neurological episode. The favorable outcome following reduced-dose reintroduction demonstrates that permanent treatment discontinuation was not required in this patient and supports an individualized approach to subsequent chemotherapy.

Authors

Institutions

Publication Details

Journal
Cureus
Published
2026-11-18
DOI
https://doi.org/10.7759/cureus.119863
Primary Topic
Cancer Treatment and Pharmacology
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Diffuse Cytotoxic Lesions of the Corpus Callosum Following Folinic Acid, Fluorouracil, and Oxaliplatin (FOLFOX) Chemotherapy: A Case Report

Youssouf Benmoh, Najoua Mouloudi, Houda Alloussi, Manal Bourrouk et al.
3 links
Cureus
Cancer Treatment and Pharmacology
article

Diffuse Cytotoxic Lesions of the Corpus Callosum Following Folinic Acid, Fluorouracil, and Oxaliplatin (FOLFOX) Chemotherapy: A Case Report

Youssouf Benmoh, Najoua Mouloudi, Houda Alloussi, Manal Bourrouk, Ahmed Bourazza
article en

Abstract

Cytotoxic lesions of the corpus callosum (CLOCCs) are a neuroradiological pattern associated with diverse conditions, including drug-related toxicity. Although commonly centered in the splenium, lesions may extend throughout the corpus callosum and into adjacent white matter. We report the case of a 38-year-old woman with metastatic colonic adenocarcinoma who developed acute confusion and visual disturbances four days after initiation of her first cycle of folinic acid, fluorouracil, and oxaliplatin (FOLFOX). Neurological examination revealed right-eye exotropia without motor or sensory deficits. Laboratory investigations, including serum ammonia, were unremarkable. Brain magnetic resonance imaging (MRI) demonstrated bilateral, symmetric T2-weighted/fluid-attenuated inversion recovery (FLAIR) hyperintensities involving the entire corpus callosum and periventricular white matter, with restricted diffusion, reduced apparent diffusion coefficient (ADC), and no contrast enhancement. These findings supported a diagnosis of FOLFOX-associated CLOCCs, potentially related to 5-fluorouracil (5-FU) neurotoxicity. Complete neurological recovery occurred within 24 hours, and follow-up MRI at one month showed complete resolution. FOLFOX was subsequently resumed with a 25% reduction in the 5-FU dose and close monitoring, without neurological recurrence or other observed complications. This case illustrates that extensive callosal involvement can accompany a rapidly reversible neurological episode. The favorable outcome following reduced-dose reintroduction demonstrates that permanent treatment discontinuation was not required in this patient and supports an individualized approach to subsequent chemotherapy.

Cureus
Mohammed V University (MA)
Good health and well-being
Cancer Treatment and Pharmacology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon